Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03914703 · ClinicalTrials.gov registry record
MDR EZ Pass and Precision Flexible Reamer
A clinical trial, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 73
- Enrollment target
NCT03914703: Completed study, sponsored by Zimmer Biomet.
NCT03914703 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03914703 has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
Study Summary
The objective of this study is to confirm the safety and performance on the EZPass Suture Passer Instrumentation and the Precision Flexible Reamer Instrumentation.
Primary Outcome
Questionnaire was completed to assess if the Instrument Performed as Expected. Surgeon provided yes/no answers on their opinion if the instrument performed as expected during the procedure.
Interventions
- PROCEDURE EZ Pass Suture Passer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2019-08-08 |
| Est. Completion | 2024-04-08 |
What the finished NCT03914703 record still lists
NCT03914703 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 73 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which EZ Pass Suture Passer is the first listed.
NCT03914703 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03914703 about?
NCT03914703 is a clinical study titled "MDR EZ Pass and Precision Flexible Reamer". The objective of this study is to confirm the safety and performance on the EZPass Suture Passer Instrumentation and the Precision Flexible Reamer Instrumentation.
What is the current status of trial NCT03914703?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2019-08-08. Estimated completion is 2024-04-08.
What interventions are being tested in trial NCT03914703?
The interventions under investigation include: EZ Pass Suture Passer (PROCEDURE).
Who is sponsoring clinical trial NCT03914703?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI